AAAAAA

   
Results: 1-25 |
Results: 25
ANALYSIS OF LYMPH-NODE BIOPSIES IN HIV-INFECTED PATIENTS BEFORE AND AFTER HAART
Authors: BUCY RP KILBY JM DERDEYN CA HORTON D SILLERS M SQUIRES K SAAG M SHAW GM HOCKETT RD
Citation: Rp. Bucy et al., ANALYSIS OF LYMPH-NODE BIOPSIES IN HIV-INFECTED PATIENTS BEFORE AND AFTER HAART, The FASEB journal, 12(4), 1998, pp. 1719-1719
ITRACONAZOLE MAINTENANCE TREATMENT FOR HISTOPLASMOSIS IN AIDS - A PROSPECTIVE, MULTICENTER TRIAL
Authors: HECHT FM WHEAT J KORZUN AH HAFNER R SKAHAN KJ LARSEN R LIMJOCO MT SIMPSON M SCHNEIDER D KEEFER MC CLARK R LAI KK JACOBSON JM SQUIRES K BARTLETT JA POWDERLY W
Citation: Fm. Hecht et al., ITRACONAZOLE MAINTENANCE TREATMENT FOR HISTOPLASMOSIS IN AIDS - A PROSPECTIVE, MULTICENTER TRIAL, Journal of acquired immune deficiency syndromes and human retrovirology, 16(2), 1997, pp. 100-107
PHASE-I DOSE-ESCALATION PHARMACOKINETICS OF AZT-P-DDI (IVX-E-59) IN PATIENTS WITH HUMAN-IMMUNODEFICIENCY-VIRUS
Authors: ZHOU XJ SQUIRES K PANZHOU XR BERNHARD S AGROFOGLIO L KIRK M DUCHIN KL SOMMADOSSI JP
Citation: Xj. Zhou et al., PHASE-I DOSE-ESCALATION PHARMACOKINETICS OF AZT-P-DDI (IVX-E-59) IN PATIENTS WITH HUMAN-IMMUNODEFICIENCY-VIRUS, Journal of clinical pharmacology, 37(3), 1997, pp. 201-213
PHARMACOKINETICS OF SAQUINAVIR, ZIDOVUDINE, AND ZALCITABINE IN COMBINATION THERAPY
Authors: VANHOVE GF KASTRISSIOS H GRIES JM VEROTTA D PARK KS COLLIER AC SQUIRES K SHEINER LB BLASCHKE TF
Citation: Gf. Vanhove et al., PHARMACOKINETICS OF SAQUINAVIR, ZIDOVUDINE, AND ZALCITABINE IN COMBINATION THERAPY, Antimicrobial agents and chemotherapy, 41(11), 1997, pp. 2428-2432
TREATMENT OF CRYPTOCOCCAL MENINGITIS ASSOCIATED WITH THE ACQUIRED-IMMUNODEFICIENCY-SYNDROME
Authors: VANDERHORST CM SAAG MS CLOUD GA HAMILL RJ GRAYBILL JR SOBEL JD JOHNSON PC TUAZON CU KERKERING T MOSKOVITZ BL POWDERLY WG DISMUKES WE RISER L THOMAS C LACKE C WHITE AC PATTERSON S DAVIS D FLANIGAN C HARDEN T PHILLIPS D ULLOM I VASQUEZ J MCMULLEN S FLOWERS D BOSHA M BRITTON M FISHER JF NEWMAN C WILLIS B HENDERSON H JOHNSON E DUNGO L PIERCE M MORGAN M STERN J PETROSKY N BAMBERGER D FARNAN R FEINBERG J APUZZO L ROYAL W THOMPSON S BARRETT K KAUFFMAN C GUTSCH H MCKINSEY D LEE B HYSLOP N GREENSPAN D STRATA R FESSEL WJ VANRAALTE G PANKEY G SCHNEIDER D BRIGGS ND PIERCE D LEE S VANGNESS I LONGMIRE B STANSELL J JACOBSON M GRAY D COLEMAN R VOORHEES J KLEBERT M ROYAL M MILDVAN D FRIEDLAND G COONEY E WALESKY M LEEDOM JM LARSEN R DIAMOND D WHEAT LJ NIXON H CRAFT J NEIDIG JL FASS RJ RUSSELL J MACGREGOR RR KAPPES R TSELIS A SKAHAN KJ JACKSON B DANIEL P PAULSONWHITE C HEWITT R COHN S LEWIS M GREISBERGER C HELLER H SUGAR A KARCHMER AW FITCH H FLAM R JOSEPH M ELSADR W SOEIRO R STEIN D ZINGMAN B POLLARD R HAUSRATH S WATERMAN K SQUIRES K PONTICELLO L GRIECO M HAFNER R DIXON D
Citation: Cm. Vanderhorst et al., TREATMENT OF CRYPTOCOCCAL MENINGITIS ASSOCIATED WITH THE ACQUIRED-IMMUNODEFICIENCY-SYNDROME, The New England journal of medicine, 337(1), 1997, pp. 15-21
CYTOMEGALOVIRUS (CMV) CULTURE RESULTS, DRUG-RESISTANCE, AND CLINICAL OUTCOME IN PATIENTS WITH AIDS AND CMV RETINITIS TREATED WITH FOSCARNETOR GANCICLOVIR
Authors: LEWIS RA CLOGSTON P FAINSTEIN V GROSS R SAMO T TUTTLE C JABS DA APUZZO L BARTLETT J COLESON L DUNN JP ELDRED L FEINBERG J FLYNN T KING R LESLIE J BARRON B GREENSPAN D LECOUNT C PEYMAN G FRANKLIN R HEINEMANN MH POLSKY B SQUIRES K WISECAMPBELL S FRIEDMAN AH CHEUNG AW JUSTIN N TEICH S SACKS H SEVERIN C FRIEDBERG DN ADDESSI A DIETERICH D FROST K WEINBERG D JAMPOL L MURPHY R NAUGHTON K HENDERLY D HOLLAND GN CHAFEY S FALL H HARDY WD KIMBRELL C MACARTHURCHANG L FREEMAN WR MEIXNERT L PETERSON TJ QUICENO JI RICKMAN L SIMANELLO MA SPECTOR S ODONNELL J HOFFMAN J IRVINE A JACOBSON M LARSON J SEIFF S WANNER M DAVIS J CHUANG E ESPINAL M MENDEZ P VANDENBROUCKE R DODGE JM STEVENS M BROWNBELLAMY J KLEMM AC MARKOWITZ JA WEBB R MEINERT CL AMENDLIBERCCI D COLESONSCHREUR L COLLINS KL COLLISON BJ DODGE J DONITHAN M FINK N KAPLANGILPIN AM GERCZAK C HOLBROOK JT ISAACSON MR LANE MF LEVINE CR MARTIN BK MIN YI OWENS RM NOWAKOWSKI DJ SAAH A TONASCIA J VANNATTA ML DAVIS MD AGRESSEGAL M ARMSTRONG J BROTHERS R FREITAG G HUBBARD L HURLBURT D KASTORFF L MAGLI Y MINER K THOMAS S VANDERHOOFYOUNG M DREW WL MINOR R STEWART G HUGHES R WELCH L MOWERY R ELLENBERG S KORVICK J SATTLER F BROWN BW CONWAY B GRIZZLE J NUSSENBLATT R PHAIR J SMITH H WHITLEY R
Citation: Ra. Lewis et al., CYTOMEGALOVIRUS (CMV) CULTURE RESULTS, DRUG-RESISTANCE, AND CLINICAL OUTCOME IN PATIENTS WITH AIDS AND CMV RETINITIS TREATED WITH FOSCARNETOR GANCICLOVIR, The Journal of infectious diseases, 176(1), 1997, pp. 50-58
FOSCARNET-GANCICLOVIR CYTOMEGALOVIRUS RETINITIS TRIAL .5. CLINICAL-FEATURES OF CYTOMEGALOVIRUS RETINITIS AT DIAGNOSIS
Authors: LEWIS RA CLOGSTON P FAINSTEIN V GROSS R SAMO T TUTTLE C JABS DA APUZZO L BARTLETT J COLESON L DUNN JP ELDRED L FEINBERG J FLYNN T KING R LESLIE J BARRON B GREENSPAN D LECOUNT C PEYMAN G FRANKLIN R HEINEMANN MH POLSKY B SQUIRES K WISECAMPBELL S FRIEDMAN AH CHEUNG TW JUSTIN N TEICH S SACKS H SEVERIN C FRIEDBERG DN ADDESSI A DIETERICH D FROST K WEINBERG D JAMPOL L MURPHY R NAUGHTON K HENDERLY D HOLLAND GN CHAFEY S FALL H HARDY WD KIMBRELL C MACARTHURCHANG L FREEMAN WR MEIXNERT L PETERSON TJ QUICENO JI RICKMAN L SIMANELLO MA SPECTOR S ODONNELL J HOFFMAN L IRVINE A JACOBSON M LARSON A SEIFF S WANNER M DAVIS J CHUANG E ESPINAL M MENDEZ P VANDENBROUCKE R CHEESEMAN SH GITTINGER J HAUBRICH R KACHADOORIAN H TOLSON K KLINE JM KLEMM AC STEVENS M WEBB R BROWNBELLAMY J MARKOWITZ JA MEINERT CL BROOKMEYER R COLLINS KB COLLISON BJ DODGE J DONITHAN M FINK N GERCZAK C GILPIN AMK HOLBROOK JT ISAACSON MR LEVINE CR MARTIN B MIN YI MEINERT JL OWENS RM NOWAKOWSKI DJ SAAH A SINGER S SMITH M STERNBERG AL TONASCIA J VANNATTA ML DAVIS MD AGRESSEGAL M ARMSTRONG J BRICKBAUER J BROTHERS R CHOP M FREITAG G HUBBARD L HURLBURT D JENSEN K KASTORFF L KING B MAGLI Y MESSING S MINER K NEIDER M STOPPENBACH V THOMAS S VANDERHOOFYOUNG M STEWART G HUGHES R WELCH L MOWERY R ELLENBERG S KORVICK J CLARK T SATTLER F BROWN BW CONWAY B GRIZZLE J NUSSENBLATT R PHAIR J SMITH H WHITLEY R
Citation: Ra. Lewis et al., FOSCARNET-GANCICLOVIR CYTOMEGALOVIRUS RETINITIS TRIAL .5. CLINICAL-FEATURES OF CYTOMEGALOVIRUS RETINITIS AT DIAGNOSIS, American journal of ophthalmology, 124(2), 1997, pp. 141-157
TREATMENT OF HISTOPLASMOSIS WITH FLUCONAZOLE IN PATIENTS WITH ACQUIRED-IMMUNODEFICIENCY-SYNDROME
Authors: WHEAT J MAWHINNEY S HAFNER R MCKINSEY D CHEN DF KORZUN A SHAKAN KJ JOHNSON P HAMILL R BAMBERGER D PAPPAS P STANSELL J KOLETAR S SQUIRES K LARSEN RA CHEUNG T HYSLOP N LAI KK SCHNEIDER D KAUFFMAN C SAAG M DISMUKES W POWDERLY W
Citation: J. Wheat et al., TREATMENT OF HISTOPLASMOSIS WITH FLUCONAZOLE IN PATIENTS WITH ACQUIRED-IMMUNODEFICIENCY-SYNDROME, The American journal of medicine, 103(3), 1997, pp. 223-232
DOSE-ESCALATING PHARMACOKINETICS OF AZT-P-DDI (IVX-E-59) AFTER SHORT-TERM INTRAVENOUS-INFUSION AND ORAL-ADMINISTRATION IN HIV-INFECTED PATIENTS
Authors: ZHOU XJ SQUIRES K BERNHARD S DELOACH L DUCHIN KL SOMMADOSSI JP
Citation: Xj. Zhou et al., DOSE-ESCALATING PHARMACOKINETICS OF AZT-P-DDI (IVX-E-59) AFTER SHORT-TERM INTRAVENOUS-INFUSION AND ORAL-ADMINISTRATION IN HIV-INFECTED PATIENTS, Clinical pharmacology and therapeutics, 59(2), 1996, pp. 103-103
ASSESSMENT OF CYTOMEGALOVIRUS RETINITIS - CLINICAL-EVALUATION VS CENTRALIZED GRADING OF FUNDUS PHOTOGRAPHS
Authors: LEWIS RA CLOGSTON P FAINSTEIN V GROSS R SAMO TC TUTTLE C JABS DA APUZZO L BARTLETT J COLESON L DUNN JP ELDRED L FEINBERG J FLYNN T KING R LESLIE J BARRON B GREENSPAN D HEINEMANN MD POLSKY B SQUIRES K WISECAMPBELL S FRIEDMAN AH CHEUNG TW JUSTIN N TEICH S SACKS H SEVERIN C FRIEDBERG DN ADDESSI A DIETERICH D FROST K WEINBERG D JAMPOL L MURPHY R NAUGHTON K HENDERLY D HOLLAND GN CHAFEY S FALL H HARDY WD KIMBRELL C MCARTHURCHANG L FREEMAN WR MEINERT L PETERSON TJ QUICENO JI RICKMAN L SIMANELLO MA SPECTOR S ODONNELL J HOFFMAN J IRVINE A JACOBSON M LARSON J SEIFF S WANNER M DAVIS J CHUANG E ESPINAL M MENDEZ P VANDENBROUCKE R CHEESMAN SH GITTINGER J HAUBRICH R KACHADOORIAN H TOLSON K KLINE JM KLEMM AC STEVENS M WEBB R BROWNBELLAMY J MARKOWITZ JA BROOKMEYER R COLLINS KB COLLISON BJ DODGE J DONITHAN M FINK N GILPIN AMK GERCZAK C HOLBROOK JT ISAACSON MR LEVINE CR MARTIN B MIN YI OWENS RM NOWAKOWSKI DJ SAAH A SINGER S SMITH M STERNBERG AL TONASCIA J VANNATTA ML DAVIES MD AGRESSEGAL M ARMSTRONG J BRICKBAUER J BROTHERS R FREITAG G HUBBARD L HURLBURT D JENSEN K KASTORFF L KING B MAGLI Y MESSING S MINER K NEIDER M ONOFREY J STOPPENBACH V THOMAS S VANDERHOOFYOUNG M STEWART G HUGHES R WELCH L KURINIJ N MOWERY R ELLENBERG S KORVICK J DAVIS MD CLARK T CLOGSTON PS FREEMAN W KOLVICK J MOWERY R SATTLER F BROWN BW CONWAY B GRIZZLE J NUSSENBLATT R PHAIR J SMITH H WHITLEY R BOWERS M CHENG B LAMBERT AG LINK D
Citation: Ra. Lewis et al., ASSESSMENT OF CYTOMEGALOVIRUS RETINITIS - CLINICAL-EVALUATION VS CENTRALIZED GRADING OF FUNDUS PHOTOGRAPHS, Archives of ophthalmology, 114(7), 1996, pp. 791-805
MEASURING VISUAL FUNCTION AND QUALITY-OF-LIFE IN PATIENTS WITH CYTOMEGALOVIRUS RETINITIS - DEVELOPMENT OF A QUESTIONNAIRE
Authors: WU AW COLESON LC HOLBROOK J JABS DA LEWIS RA CLOGSTON P FAINSTEIN V GROSS R SAMO T TUTTLE C APUZZO L BARTLETT J DUNN JP ELDRED L FEINBERG J FLYNN T KING R LESLIE J BARRON B GREENSPAN D LECOUNT C PEYMAN G FRANKLIN R HEINEMANN MH POLSKY B SQUIRES K WISECAMPBELL S FRIEDMAN AH CHEUNG AW JUSTIN N TEICH S SACKS H SEVERIN C FRIEDBERG DN ADDESSI A DIETERICH D FROST K WEINBERG D JAMPOL L MURPHY R NAUGHTON K HENDERLY D HOLLAND GN CHAFEY S FALL H HARDY WD KIMBRELL C MACARTHUR LJ FREEMAN WR MEIXNERT L PETERSON TJ QUICENO JI RICKMAN L SIMANELLO MA SPECTOR S ODONNELL J HOFFMAN J IRVINE A JACOBSON M LARSON J SEIFF S WANNER M DAVIS J CHUANG E ESPINAL M MENDEZ P VANDENBROUCKE R CHEESEMAN SH GITTINGER J HAUBRICH R KACHADOORIAN H TOLSON K KLINE JM KLEMM AC STEVENS M WEBB R BROWNBELLAMY J MARKOWITZ JA MEINERT CL BINDER KL BROOKMEYER R BROWN VE COLLISON BJ DODGE J DONITHAN M FINK N GERCZAK C HOLBROOK JT ISAACSON MR JONES CP LEVINE CR MIN YI MEINERT JL OWENS RM NOWAKOWSKI DJ SAAH A SANDFORD GR SINGER S SMITH M STERNBERG AL TONASCIA J VANNATTA ML DAVIS MD AGRESSEGAL M ARMSTRONG J BROTHERS R FREITAG G HUBBARD L HURLBURT D KASTORFF L MAGLI Y MINER K THOMAS S VANDERHOOFYOUNG M STEWART G HUGHES R WELCH L MOWERY R ELLENBERG S KORVICK J CLARK T CLOGSTON PS FREEMAN W HARDY D SATTLER F JORDAN C MILLS J BROWN BW CONWAY B GRIZZLE J NUSSENBLATT R PHAIR J SMITH H
Citation: Aw. Wu et al., MEASURING VISUAL FUNCTION AND QUALITY-OF-LIFE IN PATIENTS WITH CYTOMEGALOVIRUS RETINITIS - DEVELOPMENT OF A QUESTIONNAIRE, Archives of ophthalmology, 114(7), 1996, pp. 841-847
CLINICAL VS PHOTOGRAPHIC ASSESSMENT OF TREATMENT OF CYTOMEGALOVIRUS RETINITIS - FOSCARNET-GANCICLOVIR CYTOMEGALOVIRUS RETINITIS TRIAL REPORT-8
Authors: LEWIS RA CLOGSTON P FAINSTEIN V GROSS R SAMO TC TUTTLE C JABS DA APUZZO L BARTLETT J COLESON L DUNN JP ELDRED L FEINBERG J FLYNN T KING R LESLIE J BARRON B GREENSPAN D LECOUNT C PEYMAN G FRANKLIN R HEINEMANN MH POLSKY B SQUIRES K WISECAMPBELL S FRIEDMAN AH CHEUNG TW JUSTIN N TEICH S SACKS H SEVERIN C ADDESSI A DIETERICH D FROST K WEINBERG D JAMPOL L MURPHY R NAUGHTON K HENDERLY D HOLLAND GN CHAFEY S FALL H HARDY WD KIMBRELL C MACARTHURCHANG L FREEMAN WR MEINERT L PETERSON TJ QUICENO JI RICKMAN L SIMANELLO MA SPECTOR S ODONNELL J HOFFMAN J IRVINE A JACOBSON M LARSON J SEIFF S WANNER M DAVIS J CHUANG E ESPINAL M MENDEZ P VANDENBROUCKE R CHEESMAN SH GITTINGER J HAUBRICH R KACHADOORIAN H TOLSON K KLINE JM KLEMM AC STEVENS M WEBB R BROWNBELLAMY J MARKOWTIZ JA MEINERT CL BROOKMEYER R COLLINS KB COLLISON BJ DODGE J DONITHAN M FINK N GILPIN AMK GERCZAK C HOLBROOK JT ISAACSON MR LEVINE CR MARTIN B MIN YI MEINERT JL OWENS RM NOWAKOWSKI DJ SAAH A SINGER S SMITH M STERNBERG AL TONASCIA J VANNATTA ML DAVIS MD AGRESSEGAL M ARMSTRONG J BRICKBAUER J BROTHERS R FREITAG G HUBBARD L HURLBURT D JENSEN K KASTORFF L KING B MAGLI Y MESSING S MINER K NEIDER M ONOFREY J STOPPENBACH V THOMAS S VANDERHOOFYOUNG M STEWART G HUGHES R WELCH L KURINIJ N MOWERY R ELLENBERG S KORVICK J CLARK T CLOGSTON PS FREEMAN W HOLBROOK JT KOLVICK J MARKOWITZ JA SATTLER F CONWAY B GRIZZLE J NUSSENBLATT R PHAIR J SMITH H WHITLEY R CHENG B LAMBERT AG LINK D
Citation: Ra. Lewis et al., CLINICAL VS PHOTOGRAPHIC ASSESSMENT OF TREATMENT OF CYTOMEGALOVIRUS RETINITIS - FOSCARNET-GANCICLOVIR CYTOMEGALOVIRUS RETINITIS TRIAL REPORT-8, Archives of ophthalmology, 114(7), 1996, pp. 848-855
COMBINATION FOSCARNET AND GANCICLOVIR THERAPY VS MONOTHERAPY FOR THE TREATMENT OF RELAPSED CYTOMEGALOVIRUS RETINITIS IN PATIENTS WITH AIDS - THE CYTOMEGALOVIRUS RETREATMENT TRIAL
Authors: LEWIS RA CARR LM DOYLE K FAINSTEIN V GROSS R PASKELL H SAMO TC SHIGLEY JW JABS DA BARTLETT J BECKER R COLESON LC DUNN JP FEINBERG J TAYKEARNEY ML LESLIE J MILLER T NEISSER LG SEMBA RD BARRON B JARROTT C LECOUNT C PEYMAN G SWENIE D HEINEMANN M OLEARY C POLSKY B SQUIRES K WISECAMPBELL S FRIEDMAN AH CHEUNG TW JUSTIN N SACKS H SEVERIN C TEICH S WALLACH F FRIEDBERG DN ADDESSI A DIETERICH D FROST K HUTT R PEI M POWERS T SCOPPE C WEINBERG DV JAMPOL L LYON A MUNANA A MURPHY R NAUGHTON K PALELLA F RICHINE L VALADEZ G KIMBLE JA WEINGARTEN J HOLLAND GN CHAFEY S HARDY D JOHIRO AK KIMBRELL C LEVINSON RD MACARTHUR LJ MARTIN M TUFAIL A FREEMAN WR AREVALOCOLINA JF CLARK T JARMAN CL MEIXNER L MENG TC SIMANELLO MA SPECTOR S ODONNELL J BUSH T HOFFMAN J IRVINE A JACOBSON M LARSON J PAYNE M SEIFF S WANNER M DAVIS J CABREJOS C MENDEZ P MURRY T VANDENBROUCKE R VANDERHORST C KYLSTRA J LATKIN S WOHL D DODGE JM KLEMSTINE JL SCHUERHOLTZ TA STEVENS M KLEMM AC WEBB RM MEINERT CL AMENDLIBERCCI D BATES K COLLINS KL COLLISON BJ DONITHAN M EWING C FINK N GERCZAK C HARLE J TOLBROOK JT HUFFMAN R ISAACSON MR GILPIN AMK LEVINE CR MARTIN B NOWAKOWSKI DJ OWENS RM SAAH A SMITH M SUN F TONASCIA J VANNATTA ML WU A DAVIS MD ARMSTRONG J BRICKBAUER J BROTHERS R CHOP M HUBBARD L HURLBERT D KASTORFF L MAGLI Y NEIDER M STOPPENBACH V VANDERHOOFYOUNG M WALLS M HUGHES R MOWERY RL ALSTON B FOULKES M FREEMAN W HOLBROOK J HOLLAND G DUNCAN WR KESSLER H KORVICK J LAMBERT G SCHNITTMAN S BROWN BW CONWAY B GRIZZLE J NUSSENBLATT R PHAIR JP SMITH H WHITLEY R CHENG B LINK D
Citation: Ra. Lewis et al., COMBINATION FOSCARNET AND GANCICLOVIR THERAPY VS MONOTHERAPY FOR THE TREATMENT OF RELAPSED CYTOMEGALOVIRUS RETINITIS IN PATIENTS WITH AIDS - THE CYTOMEGALOVIRUS RETREATMENT TRIAL, Archives of ophthalmology, 114(1), 1996, pp. 23-33
OVERVIEW - HIV-INFECTION IN WOMEN
Authors: SQUIRES K
Citation: K. Squires, OVERVIEW - HIV-INFECTION IN WOMEN, Pediatric AIDS and HIV infection, 6(3), 1995, pp. 151-153
DRAMATIC DECREASE IN TUBERCULIN SKIN-TEST CONVERSION RATE AMONG EMPLOYEES AT A HOSPITAL IN NEW-YORK-CITY
Authors: FELLA P RIVERA P HALE M SQUIRES K SEPKOWITZ K
Citation: P. Fella et al., DRAMATIC DECREASE IN TUBERCULIN SKIN-TEST CONVERSION RATE AMONG EMPLOYEES AT A HOSPITAL IN NEW-YORK-CITY, American journal of infection control, 23(6), 1995, pp. 352-356
POPULATION PHARMACOKINETICS OF STAVUDINE (D4T) IN PATIENTS WITH AIDS OR ADVANCED AIDS-RELATED COMPLEX
Authors: HORTON CM DUDLEY MN KAUL S MAYER KH SQUIRES K DUNKLE L ANDERSON R
Citation: Cm. Horton et al., POPULATION PHARMACOKINETICS OF STAVUDINE (D4T) IN PATIENTS WITH AIDS OR ADVANCED AIDS-RELATED COMPLEX, Antimicrobial agents and chemotherapy, 39(10), 1995, pp. 2309-2315
POPULATION DIFFERENCES IN GANCICLOVIR CLEARANCE AS DETERMINED BY NONLINEAR MIXED-EFFECTS MODELING
Authors: YUEN GJ DRUSANO GL FLETCHER C CAPPARELLI E CONNOR JD LALEZARI JP DREW L FOLLANSBEE S BUSCH D JACOBSON M SPECTOR SA SQUIRES K BUHLES W
Citation: Gj. Yuen et al., POPULATION DIFFERENCES IN GANCICLOVIR CLEARANCE AS DETERMINED BY NONLINEAR MIXED-EFFECTS MODELING, Antimicrobial agents and chemotherapy, 39(10), 1995, pp. 2350-2352
ANTIVIRAL EFFECTS OF FOSCARNET AND GANCICLOVIR THERAPY ON HUMAN-IMMUNODEFICIENCY-VIRUS P24 ANTIGEN IN PATIENTS WITH AIDS AND CYTOMEGALOVIRUS RETINITIS
Authors: QUINN TC JABS DA HOLBROOK JT HARDY WD POLSKY B LEWIS RA CLOGSTON P FAINSTEIN V GROSS R SAMO T TUTTLE C APUZZO L BARTLETT J DUNN JP ELDRED L FEINBERG J FLYNN T KING R BARRON B GREENSPAN D LECOUNT C PEYMAN G FRANKLIN R HEINEMANN M SQUIRES K WISECAMPBELL S FRIEDMAN AH CHEUNG TW JUSTIN N TEICH SA SACKS H SEVERIN C FRIEDBERG DN ADDESSI A DIETERICH D LAFLEUR F WEINBERG D JAMPOL L MURPHY R NAUGHTON K HENDERLY D HOLLAND GN CHAFEY S FALL H KIMBRELL C MACARTHUR LJ FREEMAN WR MEIXNERT L PETERSON TJ QUICENO JI RICKMAN L SIMANELLO MA SPECTOR S ODONNELL J HOFFMAN J IRVINE A JACOBSON M LARSON J SEIFF S WARNER L DAVIS J CHUANG E ESPINAL M MENDEZ P CHEESEMAN SH GITTINGER J HAUBRICH R KACHADOORIAN H TOLSON K BROWNBELLAMY J KLEMM AC MARKOWITZ JA MEINERT CL AMENDLIBERCCI A COLESON L COLLINS KL COLLISON BJ DODGE J DONITHAN M EWING C FINK N GERCZAK C ISAACSON MR KAPLANGILIPIN A HUFFMAN R LEVINE CR NOWAKOWSKI DJ SMITH M TONASCIA J VANNATTA ML AGRESSEGAL M ARMSTRONG J BROTHERS R HUBBARD L HURLBURT D MAGLI Y MINER K THOMAS S VANDERHOOFYOUNG M STEWART G HUGHES R LEEF J PALMER S MOWERY R ELLENBERG S KORVICK J DAVIS MD CLARK T MERIN L SATTLER F JORDAN C MILLS J BROWN BW CONWAY B GRIZZLE J NUSSENBLATT R PHAIR J SMITH H KLINE R MOSS M CARELLA A
Citation: Tc. Quinn et al., ANTIVIRAL EFFECTS OF FOSCARNET AND GANCICLOVIR THERAPY ON HUMAN-IMMUNODEFICIENCY-VIRUS P24 ANTIGEN IN PATIENTS WITH AIDS AND CYTOMEGALOVIRUS RETINITIS, The Journal of infectious diseases, 172(3), 1995, pp. 613-621
PHARMACOKINETIC, SAFETY, AND ANTIVIRAL PROFILES OF ORAL GANCICLOVIR IN PERSONS INFECTED WITH HUMAN-IMMUNODEFICIENCY-VIRUS - A PHASE I II STUDY/
Authors: SPECTOR SA BUSCH DF FOLLANSBEE S SQUIRES K LALEZARI JP JACOBSON MA CONNOR JD JUNG D SHADMAN A MASTRE B BUHLES W DREW WL DANKNER WM MEIXNER L FREEMAN WR DYNER TS FREEMAN E MORTILLARO G GLUTZER E BUSH T COLEMAN R
Citation: Sa. Spector et al., PHARMACOKINETIC, SAFETY, AND ANTIVIRAL PROFILES OF ORAL GANCICLOVIR IN PERSONS INFECTED WITH HUMAN-IMMUNODEFICIENCY-VIRUS - A PHASE I II STUDY/, The Journal of infectious diseases, 171(6), 1995, pp. 1431-1437
INCREASED YIELD OF INTERICTAL MEG BY EEG-DIRECTED SPIKE AVERAGING
Authors: ROWLEY H KNOWLETON R ROBERTS T SQUIRES K LAXER K
Citation: H. Rowley et al., INCREASED YIELD OF INTERICTAL MEG BY EEG-DIRECTED SPIKE AVERAGING, Epilepsia, 36, 1995, pp. 143-143
MORBIDITY AND TOXIC EFFECTS ASSOCIATED WITH GANCICLOVIR OR FOSCARNET THERAPY IN A RANDOMIZED CYTOMEGALOVIRUS RETINITIS TRIAL
Authors: LEWIS RA CLOGSTON P FAINSTEIN V GROSS R SAMO T TUTTLE C JABS DA APUZZO L BARTLETT J COLESON L DUNN JP ELDRED L FEINBERG J FLYNN T KING R LESLIE J BARRON B GREENSPAN D LECOUNT C PEYMAN G FRANKLIN R HEINEMANN MH POLSKY B SQUIRES K WISECAMPBELL S FRIEDMAN AH CHEUNG TW JUSTIN N TEICH S SACKS H SEVERIN C FRIEDBERG DN ADDESSI A DIETERICH D FROST K WEINBERG D JAMPOL L MURPHY R NAUGHTON K HENDERLY D HOLLAND GN CHAFEY S FALL H HARDY WD KIMBRELL C MACARTHUR LJ FREEMAN WR MEIXNERT L PETERSON TJ QUICENO JI RICKMAN L SIMANELLO MA SPECTOR S ODONNELL J HOFFMAN J IRVINE A JACOBSON M LARSON J SEIFF S WANNER M DAVIS J CHUANG E ESPINAL M MENDEZ P VANDENBROUCKE R CHEESEMAN SH GITTINGER J HAUBRICH R KACHADOORIAN H TOLSON K KLINE JM KLEMM AC STEVENS M WEBB R BROWNBELLAMY J MARKOWITZ JA MEINERT CL BINDER KL BROOKMEYER R BROWN VE COLLISON BJ DODGE J DONITHAN M FINK N GERCZAK C HOLBROOK JT ISAACSON MR JONES CP LEVINE CR MIN YI MEINERT JL OWENS RM NOWAKOWSKI DJ SAAH A SANDFORD GR SINGER S SMITH M STERNBERG AL TONASCIA J VANNATTA ML DAVID MD AGRESSEGAL M ARMSTRONG J BROTHERS R FREITAG G HUBBARD L HURLBURT D KASTORFF L MAGLI Y MINER K THOMAS S VANDERHOOFYOUNG M STEWART G HUGHES R WELCH L MOWERY R ELLENBERG S KORVICK J DAVIS MD CLARK T CLOGSTON PS FREEMAN W SATTLER F JORDAN C MILLS J BROWN BW CONWAY B GRIZZLE J NUSSENBLATT R PHAIR J SMITH H
Citation: Ra. Lewis et al., MORBIDITY AND TOXIC EFFECTS ASSOCIATED WITH GANCICLOVIR OR FOSCARNET THERAPY IN A RANDOMIZED CYTOMEGALOVIRUS RETINITIS TRIAL, Archives of internal medicine, 155(1), 1995, pp. 65-74
ITRACONAZOLE TREATMENT OF DISSEMINATED HISTOPLASMOSIS IN PATIENTS WITH THE ACQUIRED-IMMUNODEFICIENCY-SYNDROME
Authors: WHEAT J HAFNER R KORZUN AH LIMJOCO MT SPENCER P LARSEN RA SIMPSON M SKAHAN KJ KEEFER MC CLARK R LAI KK JACOBSON JM SQUIRES K BARTLETT JA
Citation: J. Wheat et al., ITRACONAZOLE TREATMENT OF DISSEMINATED HISTOPLASMOSIS IN PATIENTS WITH THE ACQUIRED-IMMUNODEFICIENCY-SYNDROME, The American journal of medicine, 98(4), 1995, pp. 336-342
TRENDS IN THE SUSCEPTIBILITY OF TUBERCULOSIS IN NEW-YORK-CITY, 1987-1991
Authors: SEPKOWITZ KA TELZAK EE RECALDE S ARMSTRONG D ATWOOD E BERGER B BERGER J BERKOWITZ L BLEVINS A BRASSEL J BROWN A BROWN S BROWN S CHIRGWIN K CLARK E COLBY S CRUZ E CUNHA B DAVYDEEN R DECAPRARIIS P DELLALATTA P DHAR S DRUSIN L ELSADR W ERNST J FINE J GLASER J GORDON M GRIECO M HEWLETT D HOLZMAN R HOROWITZ H JENDRESKY L JENNY L JOHNSON E JORDAN M KALCUT G KAPLAN M KLEIN N LABOMBARDI V LANGE M LENOX T LERNER C LOURIA D LUTWICK L MCKINLEY W MAIR E MINUCCI D MURPHY B NEU H NICHOLAS P PAPA T PERLMAN D PETRELLO S PETTINATO B PHILLIPS S QUALE J RAHAL J RILEY L RIVERA M RYAN M SACKS H SALOMON N SCHNEIDER N SEPKOWITZ D SHAFER R SHARP V SIMBERKOFF M SMITH L SOEIRO R SPERA R SQUIRES K STEIGBIGEL N STEIGBIGEL R TAPPER M TELZAK E THELMO W TRAVERS J WEINER M WORMSER G
Citation: Ka. Sepkowitz et al., TRENDS IN THE SUSCEPTIBILITY OF TUBERCULOSIS IN NEW-YORK-CITY, 1987-1991, Clinical infectious diseases, 18(5), 1994, pp. 755-759
PHARMACOKINETICS OF L-735,524, AN HIV PROTEASE INHIBITOR
Authors: TEPPLER H OSBORNE B BJORNSSON TD POMERANTZ R WOOLF E YEH K DEUTSCH P SQUIRES K SAAG M
Citation: H. Teppler et al., PHARMACOKINETICS OF L-735,524, AN HIV PROTEASE INHIBITOR, Clinical pharmacology and therapeutics, 55(2), 1994, pp. 195-195
THERAPY FOR OROPHARYNGEAL CANDIDIASIS IN HIV-INFECTED PATIENTS - A RANDOMIZED, PROSPECTIVE MULTICENTER STUDY OF ORAL FLUCONAZOLE VERSUS CLOTRIMAZOLE TROCHES
Authors: PONS V GREENSPAN D DEBRUIN M PORETZ D SUGAR A SQUIRES K LARSEN R SATTLER F REDDING S MACPHAIL L DODD C TUAZON C POWDERLY W COCHRAN J JOSEPH WP STERN J STEIGBIGEL R KOLETAR S FOLLANSBEE S AHERN MJ DAVIDSON M JOHNSON E CHAISSON R
Citation: V. Pons et al., THERAPY FOR OROPHARYNGEAL CANDIDIASIS IN HIV-INFECTED PATIENTS - A RANDOMIZED, PROSPECTIVE MULTICENTER STUDY OF ORAL FLUCONAZOLE VERSUS CLOTRIMAZOLE TROCHES, Journal of acquired immune deficiency syndromes, 6(12), 1993, pp. 1311-1316
Risultati: 1-25 |